Wednesday, November 25, 2009, 8:36am EST - Canadian Markets open in 54 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Talecris Biotherapeutics Holdings Corp. (TLCR)

 On Nov 24: 20.18 USD   0.00 (0.00%)  
MORE ON TLCR
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Talecris Biotherapeutics Holdin (NasdaqNM:TLCR) Delayed quote dataEdit
Last Trade: 20.18 USD
Trade Time: Nov 24
Change: 0.00 (0.00%)
Prev Close: 20.18
Open: N/A
Bid: 19.27 x 100
Ask: 20.88 x 300
1y Target Est: 25.40
Day's Range: N/A - N/A
52wk Range: 18.01 - 23.44
Volume: 0
Avg Vol (3m): 1,382,090
Market Cap: 2.42B
P/E (ttm): 10.68
EPS (ttm): 1.89
Div & Yield: N/A (N/A%)
Talecris Biotherapeutics Holdings Corp. (TLCR)
1d  5d  3m 
Free Annual Reports
 Add TLCR to Portfolio   Download Data

HEADLINES
• Biotech Stocks Hot Right Now, Ho-Hum in the Long Run
at The Wall Street Journal Online (Wed, Nov 18)
• Talecris to invest $268.7 million in NC plant
AP (Fri, Nov 13)
• Talecris to Invest $268.7 Million to Expand its Manufacturing Facility in Clayton
Business Wire (Fri, Nov 13)
• There Will Be Blood (Plasma)
at Motley Fool (Wed, Nov 11)
• Coverage initiated on Talecris Biotherapeutics by Barclays Capital and Citigroup
Briefing.com (Wed, Nov 11)
• Talecris Biotherapeutics Holdings Corp. Earnings Call scheduled for 8:30 am ET today
CCBN (Tue, Nov 10)
• TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial
EDGAR Online (Tue, Nov 10)
• Talecris Biotherapeutics Announces Third Quarter 2009 Results
Business Wire (Mon, Nov 9)
• TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 9)
• Q3 2009 Talecris Biotherapeutics Holdings Corp. Earnings Release - After Market Close
CCBN (Mon, Nov 9)
More Headlines for TLCR...
ANALYST
EPS Est (next year) (Dec-09) : 1.36
EPS Est (in 2 years) (Dec-10) : 1.52
Avg Rec (current)*: 2.0
PEG Ratio: 0.99
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Talecris Biotherapeutics Holdings Corp., a biotherapeutic and biopharmaceutical company, engages in the production and marketing of plasma-derived protein therapies worldwide.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices